Captopril in the protection of hearts in diabetic rats
Qian Xiao-xian,Chen Yan-ming,Wu Wei-kang,Luo Han-chuan,Liu Yong,Zhou Bin,Chen Lin,Liu Jin-lai
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.40.017
2006-01-01
Abstract:AIM: To investigate the protective effects of angiotensin converting enzyme inhibitor (ACEI),captopril on heart and its mechanism of antioxidation in diabetic rats. METHODS: ①The experiment was conducted in the Laboratory of Institute for Integrated Traditional Chinese and Western Medicine,Sun Yat-Sen University from May to November 2003. ①Thirty male adult Wistar rats of clean grade were selected and randomly divided into three groups: control group,diabetic group and captopril group with 10 rats in each group. ②The rats in the diabetic group and captopril group were induced by a single intraperitoneal injection of streptozotocin (50 mg/kg). After establishing models,the rats in the captopril group were treated orally with captopril (5 mg/kg) once a day. Those in the control group and diabetic group were given distilled water of the same volume. ③At the end of the 12th week,the rats were killed. Blood,urine and heart preparation were obtained. Urine volume,body mass,ratio of heart mass/body mass,plasma glucose,glycosylated hemoglobin (HbA1c) at hour 24 were measured. Activities of superoxide dismutase (SOD) in erythrocyte and myocardium were measured with pyrogallic acid autoxidation method. Content of malondialdehyde (MDA) in serum and myocardium was examined with modified Bamu Guofu Method. Change of myocardial ultrastructure was observed under electromicroscope. ④Mean comparison in groups was done with variance analysis and SNK test. RESULTS: One rat died in the diabetic group during the trial,so 10 rats in the control group,9 in the diabetic group and 10 in the captopril group were involved in the result analysis. ①Plasma glucose,HbA1c and ratio of heart mass/body mass in the diabetic group and captopril group were higher markedly than those in the control group (P < 0.05),and the ratio of heart mass/body mass in the captopril group (5.2±0.8)×10-3 was lower than that in the diabetic group [(5.8±0.4)×10-3,P < 0.05]. ②Activity of SOD in erythrocyte and cardiac tissues in the diabetic group and captopril group was lower obviously than that in the control group(P < 0.05),and the activities of SOD in the captopril group (6.47±0.95) μkat/L,(15.34±2.83) nkat/g were higher than those in the diabetic group [(5.25 ±1.12) μkat/L,(12.84±3.17) nkat/g,P < 0.05]. ③The contents of MDA in the serum and myocardial tissues in the diabetic group and captopril group were higher than those in the control group (P < 0.05),and those in the captopril group (33±12) nmoL/L,(800±190) nmol/g were lower than those in the diabetic group [(43±11) nmoL/L,(1 090±350) nmol/g,P < 0.05]. ④Myocardial ultrastructure was normal in the control group; Edema occurred in myocardial cells of rats in the diabetic group,and sarcomere was disordered; myofilament arranged disordered and partials were broken; mitochondrium enlarged and became round; cristae arranged disordered,even broken; Glycogen was reduced,even disappeared; myocardial ultrastructure was slightly injured in rats of the captopril group. CONCLUSION: Captopril can decrease the heart injury in diabetic rats. The mechanisms may be associated with inhibition of lipid peroxidation and enhancement of antioxidation ability due to captopril.